Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04702425 |
| Title | VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | ISR | FIN | ESP | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Uni of TX MD Anderson Cancer Cntr UT MD Anderson Cancer Ctr | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | Gent | 9000 | Belgium | Details | ||
| Novartis Investigative Site | HUS | FIN-00029 | Finland | Details | ||
| Novartis Investigative Site | Hong Kong | Hong Kong | Details | |||
| Novartis Investigative Site | Tel Aviv | 6423906 | Israel | Details | ||
| Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
| Novartis Investigative Site | Sunto Gun | Shizuoka | 411 8777 | Japan | Details | |
| Novartis Investigative Site | Seoul | 03080 | Korea, Republic of | Details | ||
| Novartis Investigative Site | Santander | Cantabria | 39008 | Spain | Details |